BMY vs MGM · P/E 17, rev $24.46B vs P/E 64, rev $4.45B
Bristol-Myers Squibb Company (BMY) versus MGM Resorts International (MGM) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US.
MGM Resorts International (MGM) is a resorts & casinos company listed on NYSE.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported MGM revenue for 2026-06-30 was $4.45B. Net income was $292.4M. Revenue was down 0.1% from 2026-03-31 to 2026-06-30. MGM currently screens at market cap $12.01B and trailing P/E 64.3.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. MGM currently screens at market cap $12.01B and trailing P/E 64.3.
Not investment advice. Open the BMY and MGM stock pages for the full models.
Not investment advice.